FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma ASCO GI 2016
Daniel Catenacci, MD of The University of Chicago Medicine discusses FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma at ASCO GI 2016
Author: ASCOGI2016
Added: 01/26/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Adenocarcinoma | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology